Apax To Buy Israel’s Syneron For $397M

April 5, 2017 | British private equity firm Apax Partners has agreed to buy Israel’s Syneron Medical Ltd. a non-surgical aesthetic device company, for $11.00 per share in cash, or a total of $397 million, the companies said on Monday. Syneron says its products have a range of applications, like body contouring, hair removal and wrinkle reduction. The products are sold under two brands, Syneron and Candela. Syneron, founded by Shimon Eckhouse in 2000, is headquartered in California with research and development offices in Israel.